Amazon Falls, Honeywell Rises, Hims & Hers Health Surges on Wegovy Deal
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On this episode of Stock Movers:
- Amazon (AMZN) shares fall after the White House Press Secretary Karoline Leavitt said that the e-commerce company’s reported decision to display the impact of tariffs on pricing was a “hostile” act. The comments from Leavitt came after Punchbowl News reported that the e-commerce giant would “soon” begin displaying the cost of US tariffs on individual products next to the total listed price.
- Honeywell (HON) shares rise after the company raised its full-year guidance for earnings per share, saying it will offset about $500 million in tariff exposure with price changes and other actions to protect its bottom line. Honeywell, which plans to split into three separate companies, will also use a multiprong approach to offsetting the impact from tariffs, it said in an investor presentation.
- Hims & Hers Health (HIMS) shares soar after the company said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms. Through NovoCare, Novo’s new direct-to-consumer pharmacy platform, Hims, LifeMD Inc., and Ro will each sell a month’s supply of Wegovy starting at $499.
See omnystudio.com/listener for privacy information.